New Deal Video Launch – New nanotherapy research for inflammatory bowel diseases

New DealNew DealLeave a Comment

Over two million people in Europe live with an inflammatory bowel disease (IBD). Besides, the number of patients is increasing and it’s become one of the most common immune-mediated diseases in young adults. Among the IBDs, Crohn’s disease and ulcerative colitis, are the most common. The current treatments include drugs and biological therapy. But, their efficacy is low and both … Read More